Home | California

Study Finds Frailty Index Can Help Predict Health-Related Quality of Life for People with Systemic Lupus Erythematosus

Study Identifies Novel Predictors of Cardiovascular Disease Risk in Women with Systemic Lupus Erythematosus

Allogene Therapeutics’ ALLO-329 Receives FDA Fast Track Designation for Three Autoimmune Conditions, Including Active Refractory Moderate-to-Severe Systemic Lupus Erythematosus

Survey Highlights the Significant Impact of Cutaneous Lupus Erythematosus on People’s Lives